Methods, plasmid vectors and primers for assessing HIV viral fitness

Details for Australian Patent Application No. 2006323930 (hide)

Owner Tibotec Pharmaceuticals Ltd. SpeeDx Pty Ltd

Inventors De Bethune, Marie-Pierre T.M.M.G; De Baere, Inky Paul Madeleine; Maes, Bart Anna Julien; Todd, Alison Velyian; Rimsky, Laurence Tatiana; Kraus, Guenter; Mokany, Elisa

Agent Shelston IP

Pub. Number AU-B-2006323930

PCT Pub. Number WO2007/065926

Priority 05111802.4 07.12.05 EP

Filing date 7 December 2006

Wipo publication date 14 June 2007

Acceptance publication date 21 June 2012

International Classifications

C12Q 1/70 Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

Event Publications

19 June 2008 PCT application entered the National Phase

  PCT publication WO2007/065926 Priority application(s): WO2007/065926

7 July 2011 Assignment before Grant

  Johnson & Johnson Research Pty Limited; Tibotec Pharmaceuticals Ltd. The application has been assigned to Tibotec Pharmaceuticals Ltd.; SpeeDx Pty Ltd 2008

21 June 2012 Application Accepted

  Published as AU-B-2006323930

18 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006323937-Magnetic polymer particles

2006323928-Bicyclic heterocyclic compounds as antiinflammatory agents